Radiotracer that detects an important contributor to neurological diseases tested for the first time in humans
Tracer that’s designed to detect demyelination, or loss of neurons’ protective coating, was safe and well tolerated.
Brain atrophy is the gradual loss of brain cells and neural connections, leading to a decrease in brain volume. It is a symptom, not a condition or disease, and may be associated with various neurological disorders.
The Neuroimmunology and Neuro-Infectious Diseases Division consists of a core group of neurologists who manage a broad array of diseases, ensuring treatment of a diverse spectrum of cases.
The Pediatric Neurology Unit at Mass General for Children diagnoses and treats infants, children and adolescents with the full spectrum of neurological conditions.
Department of Medicine
The Massachusetts General Hospital Scleroderma Program provides expert multidisciplinary care for scleroderma (systemic sclerosis) and conducts research to enhance our understanding of the disease and develop new treatments.
Read the latest news from Massachusetts General Hospital.
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
A podcast devoted to uncovering the stories of Mass General's relentless pursuit to break boundaries and provide exceptional care
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.